These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 28293092)
1. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer. Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092 [TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of Arpin in human breast cancer and its clinical significance. Liu X; Zhao B; Wang H; Wang Y; Niu M; Sun M; Zhao Y; Yao R; Qu Z J Cell Mol Med; 2016 Mar; 20(3):450-8. PubMed ID: 26648569 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer. Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949 [TBL] [Abstract][Full Text] [Related]
4. Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma. Zhang SR; Li H; Wang WQ; Jin W; Xu JZ; Xu HX; Wu CT; Gao HL; Li S; Li TJ; Zhang WH; Xu SS; Ni QX; Yu XJ; Liu L Eur J Surg Oncol; 2019 May; 45(5):769-775. PubMed ID: 30416079 [TBL] [Abstract][Full Text] [Related]
5. High expression of CD11c indicates favorable prognosis in patients with gastric cancer. Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367 [TBL] [Abstract][Full Text] [Related]
6. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients. Guo J; Dong B; Ji JF; Wu AW World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer. Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study. Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490 [TBL] [Abstract][Full Text] [Related]
9. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma. Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580 [TBL] [Abstract][Full Text] [Related]
10. Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma. Liu L; Xu X; Jing L; Zhou G; Cao Z; Han Y; Zhou R PLoS One; 2015; 10(2):e0118026. PubMed ID: 25689860 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer. Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer. Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970 [TBL] [Abstract][Full Text] [Related]
13. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer. Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221 [TBL] [Abstract][Full Text] [Related]
14. Downregulated SASH1 expression indicates poor clinical prognosis in gastric cancer. Zhou N; Liu C; Wang X; Mao Q; Jin Q; Li P Hum Pathol; 2018 Apr; 74():83-91. PubMed ID: 29320755 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer. Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316 [TBL] [Abstract][Full Text] [Related]
16. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer. Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474 [TBL] [Abstract][Full Text] [Related]
17. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients. Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595 [TBL] [Abstract][Full Text] [Related]
18. Expression and Clinical Significance of ILF2 in Gastric Cancer. Yin ZH; Jiang XW; Shi WB; Gui QL; Yu DF Dis Markers; 2017; 2017():4387081. PubMed ID: 28831206 [TBL] [Abstract][Full Text] [Related]
19. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer. Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis. Zhang J; Wu Y; Jin HY; Guo S; Dong Z; Zheng ZC; Wang Y; Zhao Y World J Gastroenterol; 2018 Nov; 24(43):4906-4919. PubMed ID: 30487700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]